The global digital biomarkers market is projected to be worth USD 10.38 Billion by 2027, according to a current analysis by Emergen Research. The Global Digital Biomarkers Market Report offers extensive knowledge and information about the Digital Biomarkers market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. These facts and figures help readers evaluate the global market growth, production, and consumption rates, volatility in demand and product prices, and upcoming market trends over the projected period. The report is formulated with the updated and latest information of the global Digital Biomarkers market further validated and verified by the industry experts and professionals. Developing nations are expected to be highly impacted, contributing to 60.0% of the global burden of chronic diseases.
The report sheds light on the mergers and acquisitions, collaborations, joint ventures, brand promotions and product launches, agreements and partnerships, and corporate and government deals. The digital biomarkers market is observing rapid growth attributed to the growing incidence of chronic diseases. The swiftly growing burden of chronic diseases across the globe are fueling the market growth. According to the statics released by WHO (World Health Organization), the burden of chronic diseases is projected to grow by 57.0% by the year 2020 from 2001. The healthcare expenditure in the US reached USD 3.60 trillion in 2018, an increase of 4.6% from the previous years. This rise in spending is, to some extent, faster as compared to the increase in 2017 from 2016.
Key Highlights From The Report
- In September 2020, Koneksa, a firm engaged in the development and implementation of patient-specific digital biomarkers for use in the drug development process, declared the completion of Series B funding round worth USD 16.0 Million. Koneska intends to deploy the fund for the integration of wearables and other patient-specific technologies into clinical research by expanding its digital platform.
- The low cost and improved scalability of digital biomarkers based on smartphone apps help in facilitating a prospective wealth of social, behavioral, psychological, and environmental data that were formerly inaccessible.
To get a sample copy of the Global Digital Biomarkers Market report, visit @ https://www.emergenresearch.com/request-sample/360
The latest research report by Emergen research, named ‘Global Digital Biomarkers Market – Forecast to 2027’, entails a comprehensive review of the global Digital Biomarkers market’s present and future trends. An increase in healthcare expenditure and increased funding for healthcare R&D are significantly driving the digital biomarkers’ market growth. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market. The pandemic has led to some devastating effects on the global economy, besides disrupting the functioning of the Digital Biomarkers industry. It offers an exhaustive analysis of the present and future effects of the pandemic on this business sphere. Moreover, the adverse effects of the coronavirus pandemic on the global Digital Biomarkers market, as well as its fundamental segments, have also been elucidated in this report.
Report Highlights:
- The report scrutinizes the salient factors influencing the growth of the market in the near future.
- Besides offering a vivid depiction of the global Digital Biomarkers business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.
- The report includes information on the present and historical market scenarios, which helps forecast the market conditions over the next eight years (2020-2027).
Key participants include AliveCor Inc., Bayer AG, Evidation Health Inc., Fitbit Inc., Happify Health, Koninklijke Philips NV, Neurotrack Technologies Inc., GlaxoSmithKline Inc., Novartis International AG, and F. Hoffmann-La Roche Ltd., among others.
To learn more details about the Global Digital Biomarkers Market report, visit @ https://www.emergenresearch.com/industry-report/digital-biomarkers-market
Additionally, the report provides an extensive analysis of the Digital Biomarkers market, including key data, such as factors influencing the growth of the market, buyers and vendors, production and consumption, and revenue. Furthermore, the report provides a comprehensive overview of the Digital Biomarkers market along with product portfolio and market performance. The report offers key insights into market share, supply chain analysis, demand and supply ratio, import/export details, and product and consumption patterns. To gain a better understanding, the report is further segmented into sections such as product types offered by the market, application spectrum, companies, and key geographical regions where the market has established its presence.
Emergen Research has segmented the global digital biomarkers market on the basis of system component, therapeutic area, end-users, and region:
- System Component Outlook (Revenue, USD Billion; 2017-2027)
- Data Collection Tools
- Digital Platforms
- Mobile Apps
- Desktop-Based Software
- Wearable
- Biosensors
- Data Integration Systems
- Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027)
- Cardiovascular Disease
- Sleep and Movement Disease
- Neurodegenerative Disorders
- Psychiatric Disorder
- Gastrointestinal Disease
- Respiratory Disease
- Diabetes
- Others
- End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Pharmaceutical Companies
- Providers
- Payers
The report aims to deliver a comprehensive understanding of the Digital Biomarkers market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Proceed To Buy: https://www.emergenresearch.com/select-license/360
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Digital Biomarkers Market Segmentation & Impact Analysis
4.1. Digital Biomarkers Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing incidence of chronic diseases
4.2.2.2. Growing geriatric population
4.2.2.3. Increasing healthcare expenditure
4.2.2.4. Increased drug development cost
4.2.3. Market restraints analysis
4.2.3.1. Cost-prohibitive digital biomarkers
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Digital Biomarkers Market By System Component Insights & Trends, Revenue (USD Million)
5.1. System Component Dynamics & Market Share, 2019 & 2027
5.1.1. Data Collection Tools
5.1.1.1. Digital Platforms
5.1.1.2. Mobile Apps
5.1.1.3. Desktop-Based Software
5.1.1.4. Wearable
5.1.1.5. Biosensors
5.1.2. Data Integration Systems
Continue…
Research Report on the Digital Biomarkers Market Addresses the Following Key Questions:
- Who are the dominant players of the Digital Biomarkers market?
- Which regional market is anticipated to have a high growth rate over the projected period?
- What consumer trends and demands are expected to influence the operations of the market players in the Digital Biomarkers market?
Request customization of the report: https://www.emergenresearch.com/request-for-customization/360
Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.
Read similar reports by Emergen Research:
Nanopharmaceutical Drugs Market @: https://www.emergenresearch.com/industry-report/nanopharmaceutical-drugs-market
Clinical Perinatal Software Market @: https://www.emergenresearch.com/industry-report/clinical-perinatal-software-market
Human Microbiome Modulators Market @: https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
In Silico Drug Discovery Market @: https://www.emergenresearch.com/industry-report/in-silico-drug-discovery-market
Prenatal Testing Market @: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
Blockchain in Genomics Market @: https://www.emergenresearch.com/industry-report/blockchain-in-genomics-market
Industrial Microbiology Market @: https://www.emergenresearch.com/industry-report/industrial-microbiology-market
Hematologic Malignancies Testing Market @: https://www.emergenresearch.com/industry-report/hematologic-malignancies-testing-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
